Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of Action of Mometasone Furoate in Seasonal Allergic Rhinitis
NCT03861559Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 1994
- Primary completion
- Jun 1994
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Mometasone Furoate with Placebo (2 arms). Primary endpoint: Median Time to Onset of Nasal Symptom Relief at Day 4. Started Mar 1994; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT03861559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03861559.